Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Leukemia, Myeloid × Idarubicin × Clear all

Phase

Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 5 Leukemia 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Leukemia, T-Cell 2 Lymphoma 1 Leukemia, Myeloid 1 Leukemia, Monocytic, Acute 1 Carcinoma, Hepatocellular 1

Interventions

fludarabine 1 Whole-Body Irradiation 1 Idarubicin 1 Daunorubicin 1 Cyclophosphamide 1 Cladribine 1 Anthracyclines 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00111345 2012-05-23

Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents

University Hospital Muenster

Phase 2/3 Unknown

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡